Significance of TP53 Mutational Status-Associated Signature in the Progression and Prognosis of Endometrial Carcinoma

Table 3

Differences in TP53 mutational status and clinicopathological variables according to the risk status in TCGA dataset.

Characteristic	High risk	Low risk
Age (years)
≤60	76	124	21.09
>60	183	134
None	0	2
BMI
≤24	42	26	5.34	0.069
>24	200	221
None	17	13
Grade
G1/2	48	162	104.78
G3	203	97
None	8	1
Stage
I/II	162	211	22.22
III/IV	97	49
None	0	0
TP53
Mut	157	42	108.51
Wild	102	218
None	0	0
Event
Alive	197	239	24.29
Dead	62	21
None	0	0